1) acitretin
阿维A酸
1.
Effect of acitretin on the proliferation and TGF-β_1 secretion of fibroblasts in systemic sclerosis;
阿维A酸对系统性硬皮病患者成纤维细胞增殖及分泌TGF-β_1的影响
2.
The Experimental Study of Proliferation-inhibiting and Differentiation-inducing Effects of Acitretin on Malignant Melanoma B16 Cells;
阿维A酸对鼠B16黑色素瘤增殖抑制及诱导分化的实验研究
3.
This article mainly introduces the effectiveness and adverse effects of acitretin and tazarotene in treatment of the patients with psoriasis.
本文重点介绍两种代表性药物——阿维A酸与他扎罗汀在银屑病临床治疗中的有关情况。
2) amoxyxillin
阿莫维酸钾
1.
The study on the stability of amoxyxillin/clavulanate potassium in three injection solution;
阿莫维酸钾与三种输液配伍的稳定性观察
3) Alverine citrate
枸橼酸阿尔维林
4) acitretin
阿维A
1.
Treatment of Psoriasis with Acitretine and Narrowband UVB:a Clinic Study;
阿维A口服联合NB-UVB照射治疗银屑病(附53例临床观察)
2.
The effect of acitretin on moderate to severe plaque psoriasis;
阿维A治疗斑块状银屑病临床疗效观察
3.
The effect of acitretin on serum MMP-2 and TIMP-2 in the patients with psoriasis vulgaris;
阿维A对寻常型银屑病患者血清MMP-2及TIMP-2的影响
5) Amoxicillin and clavulanate potassium
阿莫西林克拉维酸钾
1.
Study on formulation,preparation and dissolution of amoxicillin and clavulanate potassium(7∶1) tablets;
阿莫西林克拉维酸钾(7∶1)片处方、工艺研究及溶出度考察
6) Amoxicillin/clavulanate potassium
阿莫西林/克拉维酸钾
1.
Intravenous Drip Combined with Oral Administration Versus Sequential Therapy of Amoxicillin/Clavulanate Potassium for Lower Respiratory Tract Infection;
阿莫西林/克拉维酸钾静滴伴口服疗法与序贯疗法治疗下呼吸道感染的疗效比较
2.
Antibiotic susceptibility tests and determination of minimal inhibitory concentration(MIC) of amoxicillin/clavulanate potassium were performed.
目的了解本地区结核分枝杆菌耐药状况,为选择有效抗生素、特别新药阿莫西林/克拉维酸钾敏感性提供有效数据。
补充资料：阿维A酸
分子式：C21H26O3
分子量：326.40
CAS号：55079-83-9
性质：暂无
制备方法：暂无
用途：暂无
分子量：326.40
CAS号：55079-83-9
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条